August 2015

Deraos, G, Rodi, M, Kalbacher, H, Chatzantoni, K, Karagiannis, F, Synodinos, L, Plotas, P, Papalois, A, Dimisianos, N, Papathanasopoulos, P, Gatos, D, Tselios, T, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Mouzaki, A and Matsoukas, J (2015) Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis. European Journal of Medicinal Chemistry, 101. 13 - 23. ISSN 0223-5234

8 June 2017

Yannakakis, MP, Simal, C, Tzoupis, H, Rodi, M, Dargahi, Narges, Prakash, Monica, Mouzaki, A, Platts, JA, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Tselios, T (2017) Design and synthesis of non-peptide mimetics mapping the immunodominant myelin basic protein (MBP83–96) Epitope to function as T-cell receptor antagonists. International Journal of Molecular Sciences, 18 (6). ISSN 1661-6596

2019

Rodi, M, de Lastic, AL, Antonopoulou, S, Kylintireas, C, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Mouzaki, A (2019) Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 33 (3). pp. 92-93. ISSN 1011-6583